annual cash & cash equivalents:
$110.55M+$19.01M(+20.77%)Summary
- As of today (June 22, 2025), AMRX annual cash & cash equivalents is $110.55 million, with the most recent change of +$19.01 million (+20.77%) on December 31, 2024.
- During the last 3 years, AMRX annual cash & cash equivalents has fallen by -$137.24 million (-55.38%).
- AMRX annual cash & cash equivalents is now -67.62% below its all-time high of $341.38 million, reached on December 31, 2020.
Performance
AMRX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$59.19M-$51.37M(-46.46%)Summary
- As of today (June 22, 2025), AMRX quarterly cash & cash equivalents is $59.19 million, with the most recent change of -$51.37 million (-46.46%) on March 31, 2025.
- Over the past year, AMRX quarterly cash & cash equivalents has increased by +$12.67 million (+27.23%).
- AMRX quarterly cash & cash equivalents is now -86.91% below its all-time high of $452.10 million, reached on March 31, 2021.
Performance
AMRX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AMRX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.8% | +27.2% |
| 3 y3 years | -55.4% | -71.9% |
| 5 y5 years | -26.9% | -85.4% |
AMRX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.4% | +325.6% | -71.9% | +127.8% |
| 5 y | 5-year | -67.6% | +325.6% | -86.9% | +127.8% |
| alltime | all time | -67.6% | +325.6% | -86.9% | +127.8% |
AMRX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $59.19M(-46.5%) |
| Dec 2024 | $110.55M(+20.8%) | $110.55M(+49.4%) |
| Sep 2024 | - | $74.01M(+69.1%) |
| Jun 2024 | - | $43.77M(-5.9%) |
| Mar 2024 | - | $46.52M(-49.2%) |
| Dec 2023 | $91.54M(+252.4%) | $91.54M(+5.3%) |
| Sep 2023 | - | $86.93M(-20.5%) |
| Jun 2023 | - | $109.28M(-24.5%) |
| Mar 2023 | - | $144.67M(+457.0%) |
| Dec 2022 | $25.98M(-89.5%) | $25.98M(-70.3%) |
| Sep 2022 | - | $87.33M(-5.0%) |
| Jun 2022 | - | $91.98M(-56.3%) |
| Mar 2022 | - | $210.48M(-15.1%) |
| Dec 2021 | $247.79M | $247.79M(-18.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $302.65M(+8.7%) |
| Jun 2021 | - | $278.31M(-38.4%) |
| Mar 2021 | - | $452.10M(+32.4%) |
| Dec 2020 | $341.38M(+125.8%) | $341.38M(+21.4%) |
| Sep 2020 | - | $281.28M(+5.7%) |
| Jun 2020 | - | $266.14M(-34.3%) |
| Mar 2020 | - | $405.24M(+168.0%) |
| Dec 2019 | $151.20M(-29.1%) | $151.20M(-28.9%) |
| Sep 2019 | - | $212.74M(+287.6%) |
| Jun 2019 | - | $54.89M(-14.2%) |
| Mar 2019 | - | $63.95M(-70.0%) |
| Dec 2018 | $213.39M(+187.7%) | $213.39M(+29.2%) |
| Sep 2018 | - | $165.19M(+168.5%) |
| Jun 2018 | - | $61.52M(-17.0%) |
| Dec 2017 | $74.17M | $74.17M |
FAQ
- What is Amneal Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Amneal Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is Amneal Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of AMRX is $110.55M
What is the all time high annual cash & cash equivalents for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual cash & cash equivalents is $341.38M
What is Amneal Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, AMRX annual cash & cash equivalents has changed by +$19.01M (+20.77%)
What is Amneal Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AMRX is $59.19M
What is the all time high quarterly cash & cash equivalents for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly cash & cash equivalents is $452.10M
What is Amneal Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, AMRX quarterly cash & cash equivalents has changed by +$12.67M (+27.23%)